Please assess the completion status of the following clinical trial:

Trial Title: Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1/PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Ethnicity: all ethnic groups~* Gender: men and women~* Age~  1. Lower age limit: 40 years inclusive~ 2. Upper age limit: NONE~* BMI~  1. Lower BMI limit: 25 inclusive~ 2. Upper BMI limit: 40 inclusive~* Glucose Intolerance / Mild Diabetes defined as~  1. Fasting glucose ≥100 mg/dl OR~ 2. 2-hr glucose after OGTT ≥140 mg/dl OR~ 3. 5.8 ≤ Hemoglobin A1c ≤ 7~Major Exclusion Criteria:~* Diabetes requiring pharmacotherapy~* Smoking~* Hyperparathyroidism~* Hypercalcemia (Calcium \> 10.5 mg/dl)~* Kidney stone~* Pregnancy

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- 1 (Type: OTHER): Vitamin D3 2,000 IU daily plus Calcium Carbonate 400 mg twice daily
- 2 (Type: OTHER): Vitamin D3 2,000 IU daily plus Calcium-Placebo twice daily
- 3 (Type: OTHER): Vitamin D3-Placebo plus Calcium Carbonate 400 mg twice daily
- 4 (Type: OTHER): Vitamin D3-Placebo plus Calcium-Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).